These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10464687)

  • 1. [Comment on the report "Successful treatment of Lyell's syndrome with intravenous immunoglobulins". ("Gehört-gelesen-nachgefragt") Hautarzt (1998) 49:950-951].
    Mockenhaupt M; Schröder W
    Hautarzt; 1999 Jul; 50(7):513-4. PubMed ID: 10464687
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins.
    Paquet P; Jacob E; Damas P; Piérard GE
    Burns; 2001 Sep; 27(6):652-5. PubMed ID: 11525863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxic epidermal necrolysis (drug-induced Lyell's syndrome). 2. Treatment].
    Konstantinow A; Mühlbauer W; Balda BR; Ring J
    Dtsch Med Wochenschr; 2001 Feb; 126(7):177-9. PubMed ID: 11236525
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunomodulatory Treatment of Lyell's Syndrome: A Simultaneous Plasmapheresis and Intravenous Immunoglobulins Therapy.
    Strużyna J; Surowiecka A; Korzeniowski T; Piszczek J; Korulczyk P; Drozd L; Stachura A; Torres K; Krajewski A
    J Burn Care Res; 2022 Nov; 43(6):1394-1398. PubMed ID: 35396849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemolysis secondary to high-dose intravenous immunoglobulin in a patient with Stevens-Johnson syndrome.
    Shakouri AA; Bahna SL
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):463-4. PubMed ID: 22626604
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-drug-induced Stevens-Johnson syndrome successfully treated with high-dose i.v. immunoglobulin.
    Nozaki Y; Fujita H; Okada R; Kou K; Aihara M
    J Dermatol; 2015 Apr; 42(4):439-40. PubMed ID: 25753003
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case of successful treatment of severe form of Lyell's syndrome].
    Mansurova TP; Kamartdinova ZA; Kokh KV; Tokarev VA
    Pediatriia; 1982 Oct; (10):61. PubMed ID: 7177753
    [No Abstract]   [Full Text] [Related]  

  • 8. The timing of intravenous immunoglobulin therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Yeung CK; Lam LK; Chan HH
    Clin Exp Dermatol; 2005 Sep; 30(5):600-2. PubMed ID: 16045716
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.
    French LE; Trent JT; Kerdel FA
    Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the outcome of patients with toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Stern RS
    Arch Dermatol; 2000 Mar; 136(3):410-1. PubMed ID: 10724207
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of intravenous immunoglobulin in toxic epidermal necrolysis.
    Feldmeyer L; Kerdel FA; French LE
    Arch Dermatol; 2011 Dec; 147(12):1440-1. PubMed ID: 22184768
    [No Abstract]   [Full Text] [Related]  

  • 12. [Toxic epidermal necrolysis treated with intravenous immunoglobulins].
    Corne P; Dereure O; Guilhou JJ; Jonquet O
    Rev Med Interne; 2001 May; 22(5):491-2. PubMed ID: 11402525
    [No Abstract]   [Full Text] [Related]  

  • 13. Wound care for Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Castillo B; Vera N; Ortega-Loayza AG; Seminario-Vidal L
    J Am Acad Dermatol; 2018 Oct; 79(4):764-767.e1. PubMed ID: 29601936
    [No Abstract]   [Full Text] [Related]  

  • 14. Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fromowitz JS; Ramos-Caro FA; Flowers FP;
    Int J Dermatol; 2007 Oct; 46(10):1092-4. PubMed ID: 17910723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Treat J
    Pediatr Ann; 2010 Oct; 39(10):667-9, 672-4. PubMed ID: 20954613
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ophthalmological treatment of Lyell's syndrome].
    Haus C; Paquet P; Maréchal-Courtois C
    Rev Med Liege; 1993 Jul; 48(7):395-400. PubMed ID: 8367638
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of toxic epidermal necrolysis treated with intravenous immunoglobin.
    Magina S; Lisboa C; Gonçalves E; Conceição F; Leal V; Mesquita-Guimarães J
    Br J Dermatol; 2000 Jan; 142(1):191-2. PubMed ID: 10819555
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of toxic epidermal necrolysis in AIDS with intravenous immunoglobulins.
    Tan A; Tan HH; Lee CC; Ng SK
    Clin Exp Dermatol; 2003 May; 28(3):269-71. PubMed ID: 12780710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of hemosorption in a 10-month-old infant with Lyell's syndrome].
    Muravko LS; Dorozhkova IA; Tolkachev BG
    Pediatriia; 1988; (1):94. PubMed ID: 3362624
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of effective treatment of Lyell's syndrome using hemosorption].
    Mamichev VI; Dyrul AK; Derkho VG; Belonogov MN
    Pediatriia; 1987; (7):93-4. PubMed ID: 3671015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.